100% Quality Guarantee
PhD-Level Technical Support
Arevirumab-3 Antibody - SDS-PAGE
Key Features

Arevirumab-3 Antibody (GXBS01478)

SKU GXBS01478
Product Type Research Grade Biosimilar
Antibody Type Monoclonal
Host Species Human
Reactivity Lassa virus (LASV)
Applications ELISA, FACS, Functional assay, Research in vivo
Isotype IgG1-kappa
$616 - $1,965

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Arevirumab-3 Antibody

Arevirumab-3 Antibody is a research-grade biosimilar monoclonal antibody targeting GPC. It is a human IgG1-kappa antibody. Reactivity: Lassa virus (LASV). Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.

Pre-glycoprotein polyprotein GP complex (GPC) is a ~55 kDa protein. Functions as a cleaved signal peptide that is retained as the third component of the GP complex (GP-C). Helps to stabilize the spike complex in its native conformation. The SSP is required for efficient glycoprotein expression, post-translational maturation cleavage of G1 and G2, glycoprotein transport to the cell surface plasma membrane, formation of infectious virus particles, and acid pH-dependent glycoprotein-mediated cell fusion.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose